Gapping up
In reaction to earnings/guidance:
- SGH +12.8% SAP +5.3% PNFP +2% BLK +1.5% JPM +0.6%
Other news:
- RVNC +10.1% (continues to anticipate FDA approval of DaxibotulinumtoxinA this year)
- ALYA +7.3% (awarded a 3-year contract to accompany a major Quebec government ministry in accelerating its digital transformation agenda)
- VMEO +6.7% (provides metrics for Sept; subscribers increased 14% yr/yr in the month)
- VST +6.5% (announces new $2 bln share repurchase program)
- AVXL +3.5% (Independent Data Safety Monitoring Board for the Company's Phase 2b/3 Alzheimer's disease study of its investigational compound ANAVEX 2-73 has completed its recent pre-planned review of the preliminary Phase 2b/3 study data)
- CMCL +2.8% (reports record gold production in Q3)
- BCYC +2.5% (prices offering of 3240741 ADSs at $54.00 per ADS)
- FIXX +2% (announces pheEDIT Phase 1 clinical trial for HMI-103)
- CRS +1.7% (names new Chairman)
- QCOM +1.7% (approves new $10 bln stock repurchase authorization)
- PEI +1.7% (reports continued strong metrics in traffic sales and collections)
- ESTC +1.5% (expands integrations with Google Cloud)
- DCT +1.4% (announces partnership with Safekeep)
- NXPI +1.2% (names new CFO)
- ANGI +1.1% (reports monthly metrics for Sep)
- TEVA +1% (reports new safety data on treatment with COPAXONE)
Analyst comments:
- PLUG +6.4% (upgraded to Overweight from Equal-Weight at Morgan Stanley)
- WEX +1.3% (upgraded to Buy from Neutral at BofA Securities)